Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in all living cells that plays essential roles in energy metabolism, cellular signaling, and DNA repair. Over the past two decades, research has documented that NAD+ levels decline with age across multiple organisms, and scientists are investigating whether this decline contributes to age-related cellular changes.
Understanding NAD+ biology provides insight into fundamental cellular processes and how they may change over time. This article explores what NAD+ is, how it functions in cells, what research shows about its decline with age, and the current state of scientific investigation into NAD+ metabolism and aging.
NAD+ is a small molecule that exists in two forms: NAD+ (oxidized) and NADH (reduced). These two forms constantly cycle between each other in redox reactions—chemical processes involving the transfer of electrons. This electron shuttling makes NAD+ absolutely essential for energy metabolism.
During glycolysis and the citric acid cycle (Krebs cycle), glucose breakdown involves the reduction of NAD+ to NADH. NADH then carries these high-energy electrons to the electron transport chain in mitochondria, where they power ATP production through oxidative phosphorylation. As NADH donates its electrons, it's oxidized back to NAD+, ready to participate in metabolism again.
Without sufficient NAD+, this cycle would halt. Glycolysis would back up, the citric acid cycle would stall, and cells would struggle to generate ATP efficiently. Research has estimated that NAD+ cycles between its oxidized and reduced forms hundreds of times per day in metabolically active cells, underscoring its central role in energy production.
In addition to its role in redox reactions, NAD+ serves as a substrate—a molecule that gets consumed—for several important enzyme families. These enzymes cleave NAD+ to power their functions, releasing nicotinamide as a byproduct. This consumption of NAD+ distinguishes these functions from its role in metabolism, where NAD+ cycles without being destroyed.
The three main enzyme families that consume NAD+ are:
Because these enzymes consume NAD+ to function, maintaining adequate NAD+ levels is important for their activity. This becomes particularly relevant when considering age-related NAD+ decline.
One of the most consistent findings in aging biology over the past 20 years has been the observation that NAD+ levels decline with age across multiple species and tissues. This has been documented in organisms ranging from yeast to worms to mice to humans.
Research in laboratory mice has shown that NAD+ levels in various tissues decline significantly with age. Studies have measured NAD+ in skeletal muscle, liver, brain, and adipose tissue, finding decreases ranging from 30-70% between young and old animals, depending on the tissue and methodology.
Similar patterns have been observed in C. elegans (roundworms) and Drosophila (fruit flies), suggesting this may be a conserved feature of aging across evolutionary distant species. The consistency of this finding across diverse organisms has made NAD+ decline one of the more reproducible observations in aging research.
Measuring NAD+ levels in humans presents more challenges than in laboratory animals, but available research suggests a similar pattern. Studies examining human muscle biopsies, skin samples, and blood cells have generally reported lower NAD+ levels in older individuals compared to younger ones.
One study examining muscle tissue from individuals aged 20-80 years found an approximately 50% reduction in NAD+ levels with age. Other research using blood cells has reported similar trends, though the magnitude varies between studies depending on methodology and the specific tissue or cell type examined.
It's important to note that measuring NAD+ is technically challenging—the molecule is sensitive to extraction methods, temperature, and processing time. Different laboratories use different protocols, which may contribute to variation in reported values. However, the general trend toward decline appears consistent across multiple research groups.
If NAD+ levels consistently decline with age, what causes this decrease? Research suggests multiple contributing factors rather than a single cause.
Cells produce NAD+ through several biosynthetic pathways. The primary pathway in mammals is the salvage pathway, which recycles nicotinamide (a breakdown product of NAD+ consumption) back into NAD+ using an enzyme called nicotinamide phosphoribosyltransferase (NAMPT).
Some studies have reported decreased expression or activity of NAMPT in aged tissues, which could reduce NAD+ synthesis capacity. Other biosynthetic enzymes in the de novo and Preiss-Handler pathways have also been examined, with mixed results across different tissues and studies.
The other side of the NAD+ balance equation is consumption by NAD+-dependent enzymes. Research has particularly focused on CD38, an enzyme that appears to increase in expression and activity with age, at least in some tissues.
Studies in mice have shown that CD38 levels increase in various tissues during aging, and that CD38-deficient mice maintain higher NAD+ levels with age compared to normal mice. This suggests that increased NAD+ consumption by CD38 may contribute to the age-related decline in NAD+ levels.
PARP activation in response to accumulated DNA damage may also consume NAD+. As DNA damage tends to accumulate with age, this could represent another drain on NAD+ pools. However, the relative contributions of different consuming enzymes remain an active area of investigation.
Much of the interest in NAD+ biology stems from its connection to sirtuins, a family of seven proteins (SIRT1-7 in mammals) that require NAD+ to function. Sirtuins are protein deacetylases—they remove acetyl groups from other proteins, changing their function.
Different sirtuins localize to different cellular compartments and have distinct roles:
Research in model organisms has shown that sirtuins influence various processes related to metabolism, stress resistance, and lifespan. For example, studies in yeast found that increasing expression of Sir2 (the yeast sirtuin) could extend replicative lifespan. Similar experiments in worms and flies have shown lifespan effects with sirtuin manipulation, though the magnitude and consistency vary.
Because sirtuins require NAD+ as a substrate, age-related decline in NAD+ could theoretically reduce sirtuin activity. This hypothesis suggests that declining NAD+ may compromise sirtuin-dependent processes that help maintain cellular function.
Research testing this hypothesis has shown that interventions that increase NAD+ levels in aged animals can restore some sirtuin-dependent markers. For instance, studies have measured increases in protein deacetylation (a sirtuin activity marker) following NAD+ precursor supplementation in aged mice.
However, it's important to note that NAD+ levels and sirtuin activity are only one part of a complex aging process. While this represents an intriguing area of research, the full picture of how NAD+-sirtuin biology relates to aging outcomes remains under investigation.
Another key NAD+-consuming process is DNA repair, particularly through the PARP (poly ADP-ribose polymerase) family of enzymes. PARPs detect DNA damage and use NAD+ to create ADP-ribose chains that recruit repair machinery to damaged sites.
When DNA damage occurs, PARP enzymes become activated and can rapidly consume large amounts of NAD+ to generate ADP-ribose polymers. Research has shown that severe DNA damage can deplete cellular NAD+ pools within minutes through PARP hyperactivation.
Under normal circumstances, this NAD+ consumption is temporary—cells regenerate NAD+ through salvage pathways once repair is complete. However, if DNA damage accumulates with age, chronic PARP activation could contribute to sustained NAD+ depletion.
Some studies have examined whether age-related NAD+ decline might compromise DNA repair capacity. The hypothesis is circular: accumulated DNA damage activates PARPs, depleting NAD+; reduced NAD+ might then compromise the repair process itself, potentially leading to more accumulated damage.
Research in cell culture has demonstrated that NAD+ availability can influence PARP-dependent repair efficiency. Studies have shown that cells with higher NAD+ levels show enhanced DNA repair kinetics in response to certain types of damage.
However, translating these cellular findings to aging in whole organisms is complex. DNA repair involves numerous pathways beyond PARPs, and many factors influence genomic stability over a lifespan. Current research suggests NAD+ availability may be one factor among many affecting DNA repair capacity, but its relative importance remains an open question.
Given the observation of NAD+ decline with age, researchers have investigated whether supplementing with NAD+ precursors—molecules that cells can convert into NAD+—might restore NAD+ levels. The main precursors studied include nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), nicotinamide (NAM), and niacin (nicotinic acid).
Studies in mice and rats have consistently shown that supplementation with NR or NMN can increase tissue NAD+ levels. Research has measured NAD+ increases in liver, muscle, brain, and other tissues following oral administration of these precursors.
Some studies have examined whether this NAD+ restoration correlates with functional outcomes in aged animals or disease models. Results have been mixed and depend heavily on the specific outcome measured, dose used, duration of treatment, and animal model examined. This is an active area of ongoing research.
Human trials with NAD+ precursors have generally demonstrated that oral supplementation can increase NAD+ levels in blood cells, with some studies also reporting increases in muscle tissue. These are preliminary findings from small trials, and research is ongoing to understand dosing, duration, and individual variability.
The critical question—whether increasing NAD+ levels in humans produces measurable functional benefits—remains under investigation. Various trials are examining different health outcomes, but this research is in early stages.
While NAD+ biology represents an exciting area of aging research, it's crucial to understand the limitations of current knowledge:
Research in this field is preliminary and ongoing. While the basic observation of NAD+ decline with age appears robust, understanding what this means for human health requires substantially more investigation.
NAD+ occupies a central position in cellular metabolism, serving both as an essential cofactor for energy production and as a substrate for enzymes involved in gene regulation and DNA repair. The consistent observation that NAD+ levels decline with age across multiple species has made this molecule a focus of aging research.
Current evidence suggests that age-related NAD+ decline results from a combination of decreased synthesis and increased consumption. This decline could theoretically affect sirtuin activity, DNA repair capacity, and other NAD+-dependent processes, potentially contributing to age-related cellular changes.
Research is ongoing to understand whether interventions that restore NAD+ levels might have functional benefits. While preclinical studies have shown that NAD+ precursors can increase tissue NAD+ levels in animals, human research is in early stages, and many questions remain unanswered.
As with all areas of aging biology, the picture is complex and multifaceted. NAD+ metabolism represents one piece of the aging puzzle, and continued research will help clarify its role and significance in the broader context of cellular aging and health.